Holen Sie sich die Stockscreener-App
3.87
0.52%
0.02
Schlusskurs vom Vortag:
$3.85
Offen:
$3.9
24-Stunden-Volumen:
270.85K
Relative Volume:
1.24
Marktkapitalisierung:
$231.74M
Einnahmen:
$32.72M
Nettoeinkommen (Verlust:
$-54.64M
KGV:
-3.4318
EPS:
-1.1277
Netto-Cashflow:
$-55.08M
1W Leistung:
-3.73%
1M Leistung:
+4.03%
6M Leistung:
-10.00%
1J Leistung:
+15.18%
1-Tages-Spanne:
$3.84
$4.005
1-Wochen-Bereich:
$3.84
$4.17
52-Wochen-Spanne:
$2.20
$5.424
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Firmenname
Orchestra Biomed Holdings Inc
Sektor
Branche
Telefon
646-343-9298
Adresse
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
3.87 | 237.73M | 32.72M | -54.64M | -55.08M | -1.1277 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Eingeleitet | TD Cowen | Buy |
| 2025-08-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-03-20 | Eingeleitet | BTIG Research | Buy |
| 2025-01-02 | Eingeleitet | Barclays | Overweight |
| 2024-08-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-25 | Eingeleitet | B. Riley Securities | Buy |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2023-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-07 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten
OBIO Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Pipeline AdvancesRevenue Recognition Risk - newsline.com
Orchestra BioMed (OBIO) Edges Higher, Testing Key Resistance Zone on Modest VolumeLow Beta Factor - newsline.com
Orchestra BioMed (NASDAQ: OBIO) CFO has shares withheld to cover RSU tax obligations - Stock Titan
Orchestra BioMed (OBIO) insider uses 6,566 shares to cover RSU taxes - Stock Titan
Orchestra BioMed Grants Equity Awards to New Employees - MyChesCo
Number of shareholders of Orchestra BioMed Holdings, Inc. – NASDAQ:OBIO - TradingView
Orchestra BioMed Holdings (OBIO) Slips 2.26% as Shares Test Support Near $3.70Chart Pattern Alerts - newsline.com
Orchestra BioMed receives $20 million from Medtronic - Investing.com
OBIO: Upcoming BackBeat and Virtue trial milestones signal strong growth and partnership-driven value - TradingView
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Insider Sell Alert: Darren Sherman Sells Shares of Orchestra Bio - GuruFocus
Insider Sell Alert: Darren Sherman Sells Shares of Orchestra BioMed Holdings Inc (OBIO) - GuruFocus
Orchestra BioMed (OBIO) director adds 5,000 shares in open-market buy - Stock Titan
Orchestra BioMed (OBIO) director Darren Sherman sells 15,000 shares under 10b5-1 plan - Stock Titan
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record
Affiliate sale notice: OBIO (NASDAQ: OBIO) proposes sale of 15,000 shares - Stock Titan
OBIO Q1 2026 Earnings: Narrower-Than-Expected Loss as Company Advances PipelineAnnual Report - newsline.com
Orchestra BioMed Holdings (OBIO) Slides 1.76% as Shares Test Key Support LevelsIron Condor Alert - thelegaladvocate.com
OBIO Q1 2026 Earnings: Narrower-Than-Expected Loss Fuels Optimism Amid Pre-Revenue StageHigh Growth Earnings - newsline.com
Orchestra BioMed (OBIO) CFO has 3,076 RSU shares withheld for taxes - Stock Titan
Orchestra BioMed (OBIO) insider reports RSU tax-withholding of 4,925 shares - Stock Titan
OBIO Q1 2026 Earnings: Loss Narrows More Than Expected, Stock Modestly DeclinesAnnual Earnings Summary - newsline.com
Orchestra BioMed (OBIO) Edges Higher: Navigating Key Support and Resistance LevelsPullback Trade - The Legal Advocate
OBIO Q1 2026 Earnings: EPS Beat Narrowed Losses, But No Revenue YetStrong Earnings Momentum - The Legal Advocate
OBIO Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline in Pre-Revenue Phase - Newser
Orchestra BioMed Holdings (OBIO) Slips Slightly as Stock Hovers Near SupportBreakaway Gap - newsline.com
OBIO Q1 2026 Earnings: Narrowed Loss as EPS Surpasses Estimates; Stock Posts Modest DeclineLong-Term Guidance - Newser
Orchestra BioMed Advances FDA Path for Hypertension Device - MyChesCo
Orchestra BioMed Targets 2027 Data for Hypertension Trial - MyChesCo
Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock - Yahoo Finance
Orchestra BioMed director Jason buys $2,493 in stock - Investing.com UK
Orchestra BioMed director Jason buys $2,493 in stock By Investing.com - Investing.com Canada
Orchestra BioMed (OBIO) director adds 665 shares in open-market buy - Stock Titan
Orchestra BioMed Holdings (OBIO) price target increased by 11.30% to 12.68 - MSN
Orchestra BioMed CEO David Hochman buys $18,850 in company stock By Investing.com - Investing.com Nigeria
Orchestra BioMed director Aryeh Jason buys $34,986 in stock By Investing.com - Investing.com Nigeria
Orchestra BioMed director Aryeh Jason buys $34,986 in stock - Investing.com India
Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference - GlobeNewswire
Orchestra BioMed CEO David Hochman buys $18,850 in company stock - Investing.com
Director at Orchestra BioMed (OBIO) buys 8,971 shares in open market - Stock Titan
B. Riley Cuts Price Target on Orchestra BioMed Holdings to $10 From $12, Keeps Buy Rating - marketscreener.com
Orchestra BioMed director Fain buys $82,600 in shares By Investing.com - Investing.com South Africa
Orchestra BioMed director Fain buys $82,600 in shares - Investing.com UK
Finanzdaten der Orchestra Biomed Holdings Inc-Aktie (OBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Orchestra Biomed Holdings Inc-Aktie (OBIO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sherman Darren | See Remarks |
Jun 01 '26 |
Sale |
3.87 |
15,000 |
58,050 |
1,184,327 |
2.60%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):